FDA Approves Pirtobrutinib for Previously Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
The FDA approved pirtobrutinib for untreated chronic lymphocytic leukemia and small lymphocytic lymphoma without 17p deletion.
ALL ABOUT DAILYZ HEALTH NEWS
ALL ABOUT DAILYZ HEALTH NEWS
September 29, 2023 8 min read Source/Disclosures Published by: Disclosures: Calabrese reports professional relationships with AbbVie, AstraZeneca, Bristol Myers Squibb,
Read MoreSeptember 29, 2023 2 min read Source/Disclosures Disclosures: Califf and Shuren report no relevant financial disclosures. ADD TOPIC TO EMAIL
Read MoreAykut Karahan | Istock | Getty Images Shares of Structure Therapeutics rose more than 30% on Friday after the biotech
Read MoreAmong patients diagnosed with Lyme disease, up to 15% will develop Lyme neuroborreliosis, an infectious disease that affects the central
Read MoreSeptember 29, 2023 1 min read Source/Disclosures Published by: Disclosures: Barocas reports no relevant financial disclosures. ADD TOPIC TO EMAIL
Read MoreSeveral members of Congress are calling on the Social Security Administration to answer for issuing billions of dollars of payments
Read MoreJOHNSON CITY, Tenn. — Five years ago, rival hospital companies in this blue-collar corner of Appalachia made a deal. If
Read MoreEmily Gebel was trying to figure out why she was having trouble breastfeeding. That’s when she felt a lump. Gebel,
Read MoreSeptember 28, 2023 2 min read Source/Disclosures Published by: Disclosures: The authors report no relevant financial disclosures. ADD TOPIC TO
Read MoreIn this photo illustration, Farxiga is made available to customers at the New City Halsted Pharmacy on August 29, 2023
Read More